1. Chen, Yunpeng, Ye, Chenxi, Chen, Jingwen, Wang, Hao, Wang, Shen. 2019. Association of the gene polymorphisms of BMPR2, ACVRL1, SMAD9 and their interactions with the risk of essential hypertension in the Chinese Han population. In Bioscience reports, 39, . doi:10.1042/BSR20181217. https://pubmed.ncbi.nlm.nih.gov/30617053/
2. Errasti Díaz, Suriel, Peñalva, Mercedes, Recio-Poveda, Lucía, Albiñana, Virginia, Cuesta, Angel M. 2022. A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2. In Journal of clinical medicine, 11, . doi:10.3390/jcm11113053. https://pubmed.ncbi.nlm.nih.gov/35683441/
3. Lu, Xiaolin, Liu, Ruiqi, Liao, Yuanyu, Liu, Chao, Zhang, Yanqiao. 2023. ACVRL1 drives resistance to multitarget tyrosine kinase inhibitors in colorectal cancer by promoting USP15-mediated GPX2 stabilization. In BMC medicine, 21, 366. doi:10.1186/s12916-023-03066-4. https://pubmed.ncbi.nlm.nih.gov/37743483/
4. Anzell, Anthony R, Kunz, Amy B, Donovan, James P, Young, Sarah, Roman, Beth L. 2024. Blood flow regulates acvrl1 transcription via ligand-dependent Alk1 activity. In Angiogenesis, 27, 501-522. doi:10.1007/s10456-024-09924-w. https://pubmed.ncbi.nlm.nih.gov/38727966/
5. Chida, Ayako, Shintani, Masaki, Wakamatsu, Hajime, Nonoyama, Shigeaki, Nakanishi, Toshio. . ACVRL1 gene variant in a patient with vein of Galen aneurysmal malformation. In Journal of pediatric genetics, 2, 181-9. doi:10.3233/PGE-13067. https://pubmed.ncbi.nlm.nih.gov/27625857/
6. Zhang, Xinyu, Zhang, Chen, Li, Qiangqiang, Zhang, Hongsheng, Gu, Hong. 2021. Clinical characteristics and prognosis analysis of idiopathic and hereditary pulmonary hypertension patients with ACVRL1 gene mutations. In Pulmonary circulation, 11, 20458940211044577. doi:10.1177/20458940211044577. https://pubmed.ncbi.nlm.nih.gov/34966542/
智鼠故事 
